C
Carol L. Armour
Researcher at Woolcock Institute of Medical Research
Publications - 227
Citations - 7888
Carol L. Armour is an academic researcher from Woolcock Institute of Medical Research. The author has contributed to research in topics: Pharmacy & Pharmacist. The author has an hindex of 48, co-authored 222 publications receiving 7391 citations. Previous affiliations of Carol L. Armour include University of Sydney & University of Technology, Sydney.
Papers
More filters
Journal ArticleDOI
Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community
Carol L. Armour,Sinthia Bosnic-Anticevich,Martha Brillant,Deborah Burton,Lynne Emmerton,Ines Krass,Bandana Saini,Lorraine Smith,Kay Stewart +8 more
TL;DR: A pharmacist-delivered asthma care programme based on national guidelines improves asthma control and the sustainability and implementation of the programme within the healthcare system remains to be investigated.
Journal ArticleDOI
RAGE and TLRs: relatives, friends or neighbours?
TL;DR: What is known about differential ligand interactions with RAGE and TLRs is discussed and important areas for further investigation are highlighted so that the role of these receptors and their relationship in host defense is better understood.
Journal ArticleDOI
Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children
Linda Hodge,Cheryl M. Salome,Julian M. Hughes,D. Liu-Brennan,J Rimmer,M Allman,D Pang,Carol L. Armour,Ann J. Woolcock +8 more
TL;DR: Dietary enrichment of omega-3 fatty acids over 6 months increased plasma levels of these fatty acids, reduced stimulated tumour necrosis factor alpha production, but had no effect on the clinical severity of asthma in these children.
Journal ArticleDOI
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.
Ines Krass,Carol L. Armour,B F Mitchell,Martha Brillant,R Dienaar,James Hughes,Phyllis Lau,Gregory M. Peterson,Kay Stewart,Susan Taylor,Jenny M. Wilkinson +10 more
TL;DR: To assess the impact of a community pharmacy diabetes service model on patient outcomes in Type 2 diabetes, a large number of patients with a history of type 2 diabetes are referred to this service.